Market Overview

Retractable Technologies, Inc. Reports Results as of June 30, 2018

Share:

Retractable Technologies, Inc. (NYSE:RVP) reports the
following results of operations for the three and six months ended June
30, 2018 and 2017, respectively. Retractable's operating loss was lower
in both the three month and six months ended June 30, 2018 than in the
three month and six months ended June 30, 2017.

Comparison of Three Months Ended June 30, 2018 and June 30, 2017

Domestic sales accounted for 84.6% and 79.2% of the revenues for the
three months ended June 30, 2018 and 2017, respectively. Domestic
revenues increased 4.4% principally due to higher volumes mitigated by
lower average sales prices. Domestic unit sales increased 11.3%.
Domestic unit sales were 79.4% of total unit sales for the three months
ended June 30, 2018. International revenue and unit sales decreased
27.4% and 33.1%, respectively, due to lower volumes. Our international
orders may be subject to significant fluctuation over time. Overall unit
sales decreased 2.1%.

The Cost of manufactured product decreased by 1.5% principally due to
lower volumes. Profit margins can fluctuate depending upon, among other
things, the cost of manufactured product and the capitalized cost of
product recorded in inventory, as well as product sales mix. Royalty
expense increased 6.9% due to increased gross sales.

Gross profit decreased 6.4% primarily due to lower sales volume.

Operating expenses decreased 14.4%. The decrease was due to lower
compensation cost, including no stock option expense in 2018, and lower
legal costs.

Our operating loss was $939 thousand compared to an operating loss for
the same period last year of $1.3 million due primarily to lower
operating costs in 2018.

Comparison of Six Months Ended June 30, 2018 and June 30, 2017

Domestic sales accounted for 85.3% and 82.4% of the revenues for the six
months ended June 30, 2018 and 2017, respectively. Domestic revenues
increased 7.6% principally due to higher sales volume mitigated by lower
average prices. Domestic unit sales increased 10.2%. Domestic unit sales
were 78.1% of total unit sales for the six months ended June 30, 2018.
International revenue and unit sales decreased 13.1% and 5.9%,
respectively, due to lower average sales prices and lower sales volume.
Our international orders may be subject to significant fluctuation over
time. Overall unit sales increased 6.2%.

The Cost of manufactured product increased 1.1% due to higher volumes
mitigated by lower unit cost. Royalty expense increased 7.2% due to
higher gross sales.

Gross profit increased 8.7% primarily due to increased revenues.

Operating expenses decreased 13.8%. The decrease was due to bonuses paid
in 2017, lower legal expense, and no stock option expense in 2018.

Our operating loss was $1.1 million compared to an operating loss for
the same period last year of $2.5 million due primarily to lower
operating expenses and higher gross profit.

Our effective tax rate on the net loss before income taxes was 0.0% for
the three and six months ended June 30, 2018 and June 30, 2017.

Further details concerning the results of operations as well as other
matters are available in Retractable's Form 10-Q filed on August 14,
2018 with the U.S. Securities and Exchange Commission.

Retractable manufactures and markets VanishPoint® and Patient
Safe® safety medical products and the EasyPoint®
needle. The VanishPoint® syringe, blood collection, and IV
catheter products are designed to prevent needlestick injuries and
product reuse by retracting the needle directly from the patient,
effectively reducing exposure to the contaminated needle. Patient Safe®
syringes are uniquely designed to reduce the risk of bloodstream
infections resulting from catheter hub contamination. The EasyPoint®
is a retractable needle that can be used with luer lock syringes, luer
slip syringes, and prefilled syringes to give injections. The EasyPoint®
needle also can be used to aspirate fluids and for blood collection.
Retractable's products are distributed by various specialty and general
line distributors.

For more information on Retractable, visit its website at www.retractable.com.

Forward-looking statements in this press release are made pursuant to
the safe harbor provision of the Private Securities Litigation Reform
Act of 1995 and reflect Retractable's current views with respect to
future events. Retractable believes that the expectations reflected in
such forward-looking statements are accurate. However, Retractable
cannot assure you that such expectations will materialize. Actual future
performance could differ materially from such statements.

Factors that could cause or contribute to such differences include, but
are not limited to: potential tariffs; Retractable's ability to maintain
liquidity; Retractable's maintenance of patent protection; the impact of
current and future Court decisions regarding current litigation;
Retractable's ability to maintain favorable third party manufacturing
and supplier arrangements and relationships; foreign trade risk;
Retractable's ability to quickly increase capacity in response to an
increase in demand; Retractable's ability to access the market;
Retractable's ability to maintain or lower production costs;
Retractable's ability to continue to finance research and development as
well as operations and expansion of production; the impact of larger
market players, specifically Becton, Dickinson and Company, in providing
devices to the safety market; and other risks and uncertainties that are
detailed from time to time in Retractable's periodic reports filed with
the U.S. Securities and Exchange Commission.

View Comments and Join the Discussion!